Levalbuterol: all 21 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD) PatientsRecruitingNCT05890638Phase 3
- Change in Oxygen Consumption Following Inhalation Beta Agonists in Healthy AdultsCompletedNCT02802111Not applicableResults posted
- Aerosolized Beta-Agonist Isomers in AsthmaCompletedNCT02170532Phase 4Results posted
- COPD Assessment and Management Bundle Versus Usual CareCompletedNCT01833026Not applicableResults posted
- Effect of Nebulized Bronchodilators on Heart RateCompletedNCT01151579Phase 4Results posted
- A Safety, Efficacy and Tolerability Study in Pediatric Subjects With AsthmaCompletedNCT00809757Phase 3Results posted
- Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED)CompletedNCT00585039Phase 4Results posted
- A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric SubjectsCompletedNCT00583947Phase 2Results posted
- Continuous Levalbuterol for Treatment of Status Asthmaticus in ChildrenCompletedNCT00124176Phase 4Results posted
- Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) PatientsActive, not recruitingNCT06040424Phase 3
- Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.Status unknownNCT05173584Phase 4
- A Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With AsthmaCompletedNCT01656811Phase 2
- Trough Bronchoprotection Conferred by Levosalbutamol and Racemic SalbutamolCompletedNCT00831376Phase 4
- Peak Bronchoprotection Conferred by Levosalbutamol and Racemic SalbutamolWithdrawnNCT00830882Phase 4
- Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) SubjectsCompletedNCT00667797Phase 4
- Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in AsthmaCompletedNCT00667407Phase 3
- Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00665600Phase 3
- Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) LesionsCompletedNCT00625521Phase 2
- Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)CompletedNCT00625157Phase 2
- Mucociliary Clearance in Healthy Subjects: Comparison of Levalbuterol and Racemic AlbuterolCompletedNCT00325767Phase 4
- Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With AsthmaCompletedNCT00073840Phase 3